↓ Skip to main content

The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats

Overview of attention for article published in Cardiovascular Diabetology, July 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 X users

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats
Published in
Cardiovascular Diabetology, July 2021
DOI 10.1186/s12933-021-01322-6
Pubmed ID
Authors

Elias Daud, Offir Ertracht, Nadav Bandel, Gassan Moady, Monah Shehadeh, Tali Reuveni, Shaul Atar

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 4 12%
Researcher 4 12%
Student > Ph. D. Student 3 9%
Student > Bachelor 3 9%
Lecturer > Senior Lecturer 1 3%
Other 3 9%
Unknown 16 47%
Readers by discipline Count As %
Medicine and Dentistry 8 24%
Biochemistry, Genetics and Molecular Biology 5 15%
Business, Management and Accounting 1 3%
Unspecified 1 3%
Agricultural and Biological Sciences 1 3%
Other 1 3%
Unknown 17 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 July 2021.
All research outputs
#7,076,697
of 23,308,124 outputs
Outputs from Cardiovascular Diabetology
#459
of 1,430 outputs
Outputs of similar age
#148,217
of 441,443 outputs
Outputs of similar age from Cardiovascular Diabetology
#20
of 42 outputs
Altmetric has tracked 23,308,124 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,430 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,443 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.